Back to Journals » International Journal of Nanomedicine » Volume 15

Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]

Authors Yin P , Li H, Ke C, Cao G, Xin X , Hu J, Cai X, Li L, Liu X, Du B

Received 28 October 2020

Accepted for publication 28 October 2020

Published 11 November 2020 Volume 2020:15 Pages 8873—8874

DOI https://doi.org/10.2147/IJN.S289131



Yin P, Li H, Ke C, et al. Int J Nanomedicine. 2020;15:1499—1515.


The authors have advised Figure 5A on page 1511 is incorrect. Due to an error at the time of figure assembly day 21 Au@PP/poly(I:C)+TMZ and day 28 Au@PP/poly(I:C)+TMZ in the HE 200× row were duplicated. The correct Figure 5 is shown below.

 

The authors apologize for this error and advise it does not affect the results of the paper.

 

Read the original article

 

Creative Commons License © 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.